C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01)
Patent
CA 2713388
This invention relates to novel sulfone 2I3-dihydroimidazo[1 12-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (P13K) in-hibition and treating diseases associated with phosphotidylinositol-3- kinase (P13K) activity, in particular treating hyper-proliferative and/or angiogenesis mediated disorders, as a sole agent or in combination with other active ingredients.
Cette invention concerne des nouveaux composés 2,3-dihydroimidazo[1,2-c]quinazoline sulfone, des compositions pharmaceutiques contenant ces composés et l'utilisation de ces composés ou de ces compositions pour inhiber la phosphotidylinositol-3-kinase (PI3K) et traiter des maladies associées à l'activité de phosphotidylinositol-3-kinase (PI3K), en particulier, pour traiter des troubles hyperproliférants et/ou induits par l'angiogénèse, comme agent unique ou combinés avec d'autres ingrédients actifs.
Bullion Ann-Marie
Guernon Leatte
Hentemann Martin F.
Johnson Jeffrey
Redman Aniko
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1832807